A contract research network of neuroscientists

What’s New in CNS Drug Development

Since 2002, 72% of all NDI studies have come from repeat clients.
NeuroDetective International: What’s New in CNS Drug Development
What’s New in
CNS Drug Development
The pre-clinical research NeuroDetective International offers is part of a larger effort to bring new therapies for CNS disorders to market. Here are highlights of the latest developments in this effort, compliments of Espicom’s CNS Drug News.

Click on any News Link to find out more.

Alzheimer's Disease

Agreements News
Product News
R&D News

Analgesics/Anaesthetics

Agreements News
Product News
R&D News

Anti-Epileptics

Agreements News
Product News
R&D News

Antidepressants

Agreements News
Product News
R&D News

Anxiolytics/Sleep Disorders

Agreements News
Product News
R&D News

Cerebrovascular

Agreements News
Product News
R&D News

Drugs used in Nausea and Vertigo

Agreements News
Product News
R&D News
To receive these updates directly, fill out the information below and someone
will contact you regarding how you can receive CNS Drug News.
 
Name and E-mail address are required fields.
 
Name:
Company Name:
Email Address:
Phone Number:
Other Areas of Interest
CNS Cancer Cardiovascular/Drugs & Devices
Diagnostics Drug Delivery Generics
Imaging Orthopedics Pharma Agreements
Home  |   About NDI  |   What"s New in CNS Drug Development  |   Consulting "Plus"  |   Animal Models of Neurological Disorders
Tests and Assays  |   In Vitro Models  |   Mouse Phenotyping  |   Addiction / Abuse Potential  |   Functional Target Validation  |   Obesity
Toxicology and Safety Assessment  |   Publications  |   About Us  |   PDF Downloads  |   Site Map

Copyright© 2006 NeuroDetective International
1422 Hopeland Road, Wyncote, PA 19095, USA

Phone: 215.536.8757
Website Design by Webfodder Website Design
by Webfodder